Related Experiment Video
Updated: Jul 5, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Coronary stenting with MGuard: from conception to human trials
Edo Kaluski1, Steve Tsai, Marc Klapholz
1Department of Cardiology, University Medical Center, University of Medicine and Dentistry of New Jersey, Newark, NJ 07101, USA. kalusked@umdnj.edu
Summary
MGuard is a novel polymer sleeve for stents designed to prevent debris release during procedures. Initial data show promise for reducing embolization and enabling drug delivery, with efficacy trials underway.
Area of Science:
- Biomaterials science
- Cardiovascular medicine
- Medical device innovation
Background:
- Distal embolization is a risk during stenting procedures.
- Current stent technology may not fully mitigate embolic events.
- Uniform drug delivery via stents remains an area for improvement.
Purpose of the Study:
- To introduce MGuard, an ultra-thin polymer sleeve for stents.
- To present theoretical considerations and scientific data supporting MGuard's use.
- To discuss the potential of MGuard for reducing embolization and drug delivery.
Main Methods:
- Development of an ultra-thin polymer sleeve (MGuard).
- Attachment of the sleeve to the external surface of stents.
- Evaluation of theoretical benefits and supporting scientific data.
Main Results:
- MGuard is designed to reduce distal embolization in various stenting procedures.
- The polymer sleeve offers potential as a platform for uniform drug delivery.
- Initial feasibility and safety data are encouraging.
Conclusions:
- MGuard represents a promising innovation for interventional cardiology.
- Further large-scale efficacy trials are in progress.
- The MGuard platform has potential future applications in treating cardiovascular disorders.
